Lifestyle-related factors in predementia and dementia syndromes

Expert Review of Neurotherapeutics

Volumn 8, Issue 1, 2008, Pages 133-158

  Solfrizzi, Vincenzo ^a   Capurso, Cristiano ^b   D'Introno, Alessia ^c   Colacicco, Anna Maria ^a   Santamato, Andrea ^b   Ranieri, Maurizio ^a   Fiore, Pietro ^b   Capurso, Antonio ^a   Panza, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c Center for Aging Brain   (Italy)

Author keywords

Alcohol; Alzheimer's disease; Dementia; Diet; Mild cognitive impairment; Monounsaturated fatty acid; Physical exercise; Polyunsaturated fatty acid; Vascular dementia

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; APOLIPOPROTEIN E; ARACHIDONIC ACID; ASCORBIC ACID; CHOLINESTERASE INHIBITOR; DOCOSAHEXAENOIC ACID; DONEPEZIL; DOPAMINE; FLUORODEOXYGLUCOSE F 18; FOLIC ACID; GALANTAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; MEMANTINE; MONOUNSATURATED FATTY ACID; NONSTEROID ANTIINFLAMMATORY AGENT; POLYUNSATURATED FATTY ACID; RIVASTIGMINE; SATURATED FATTY ACID; SEROTONIN;

AGING; ALCOHOL CONSUMPTION; ALLELE; ALZHEIMER DISEASE; CARDIOVASCULAR RISK; CAREGIVER; CEREAL; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; DEMENTIA; DIET THERAPY; DISEASE COURSE; DISEASE SEVERITY; DRINKING BEHAVIOR; DRUG MECHANISM; EDUCATION; ELDERLY CARE; EXERCISE INTENSITY; FEEDING BEHAVIOR; GENOTYPE; HUMAN; HYPERTENSION; LIFESTYLE; MEDITERRANEAN DIET; MONOTHERAPY; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; QUALITY OF LIFE; RED WINE; REVIEW; RISK FACTOR; SCORING SYSTEM; VITAMIN DEFICIENCY;

ALCOHOL DRINKING; COGNITION DISORDERS; DEMENTIA; DIET; EXERCISE; HUMANS; LIFE STYLE; PLAY AND PLAYTHINGS; RISK FACTORS;

EID: 38149045026     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.1.133     Document Type: Review

References (275)

1. D'Introno A, Panza F, Colacicco AM, Capurso A, Solfrizzi V. Mild cognitive impairment and related entities: role of vascular risk factors. In: Diet and Cognitive Decline. Panza F, Solfrizzi V, Capurso A (Eds). Nova Science Publishers, Inc., NY, USA 1-33 (2004).
2. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC, USA (1994).
3. Qiu C, De Ronchi D, Fratiglioni L. The epidemiology of the dementias: an update. Curr. Opin. Psychiatry 20, 380-385 (2007).
4. Whitehouse PJ, Sciulli CG, Mason RM. Dementia drug development: use of information systems to harmonize global drug development. Psychopharmacol. Bull. 33, 129-133 (1997).
5. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185 (1992).
6. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ. Cognitive impairment in preclinical Alzheimer's disease: a metaanalysis. Neuropsychology 18, 520-531 (2005).
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984).
8. Roman GC. Defining dementia: clinical criteria for the diagnosis of vascular dementia. Acta Neurol. Scand. Suppl. 178, 6-9 (2002).
9. Roman GC, Royall DR. Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis. Assoc. Disord. 13(Suppl. 3), S69-80 (1999).
10. Sachdev P. Vascular cognitive disorder. Int. J. Geriatr. Psychiatry 14, 402-403 (1999).
11. Roman GC, Sachdev P, Royall DR et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J. Neurol. Sci. 226, 81-87 (2004).
12. Erkinjuntti T, Inzitari D, Pantoni L et al. Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Ann. NY Acad. Sci. 903, 262-272 (2000).
13. Panza F, D'Introno A, Colacicco AM et al. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am. J. Geriatr. Psychiatry 13, 633-644 (2005).
14. Panza F, D'Introno A, Colacicco AM et al. Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol. Aging 27, 933-940 (2006).
15. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303-308 (1999).
16. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int. Psychogeriatrics 6, 63-68 (1994).
17. Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch. Neurol. 58, 1985-1992 (2001).
18. Solfrizzi V, Panza F, Colacicco AM et al. Italian Longitudinal Study on Aging Working Group, Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63, 1882-1891 (2004).
19. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357, 169-175 (2001).
20. Goldman WP, Price JL, Storandt M et al. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology 56, 361-367 (2001).
21. Morris JC, Storandt M, Miller P et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol. 58, 397-405 (2001).
22. Goate A, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706 (1991).
23. Rogaev EI, Sherrington R, Rogaeva EA et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778 (1995).
24. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 375, 754-760 (1995).
25. Panza F, D'Introno A, Colacicco AM et al. Vascular risk and genetics of sporadic lateonset Alzheimer's disease. J. Neural Transm. 111, 69-89 (2004).
26. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472 (1993).
27. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 274, 1627-1629 (1995).
28. Mayeux R, Saunders AM, Shea S et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's disease. N. Engl. J. Med. 338, 506-511 (1998).
29. Rosenberg PB, Johnston D, Lyketsos CG. A clinical approach to mild cognitive impairment. Am. J. Psychiatry 163, 1884-1890 (2006).
30. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 3, 343-353 (2004).
31. Zhang MY, Katzman R, Salmon D et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann. Neurol. 27, 428-437 (1990).
32. De Ronchi D, Fratiglioni L, Rucci P et al. The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic status. Neurology 50, 1231-1238 (1998).
33. Fratiglioni L, Grut M, Forsell Y et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 41, 1886-1892 (1991).
34. Amaducci LA, Fratiglioni L, Rocca WA et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 36, 922-931 (1986).
35. Bonaiuto S, Rocca WA, Lippi A et al. Education and occupation as risk factors for dementia: a population-based case-control study. Neuroepidemiology 14, 101-109 (1995).
36. Letenneur L, Launer LJ, Andersen K et al. Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group. Am. J. Epidemiol. 151, 1064-1071 (2000).
37. Di Carlo A, Baldereschi M, Amaducci L et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J. Am. Geriatr. Soc. 50, 41-48 (2002).
38. Evans DA, Hebert LE, Beckett LA et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch. Neurol. 54, 1399-1405 (1997).
39. Fitzpatrick AL, Kuller LH, Ives DG et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J. Am. Geriatr. Soc. 52, 195-204 (2004).
40. Graves AB, Mortimer JA, Larson EB, Wenzlow A, Bowen JD, McCormick WC. Head circumference as a measure of cognitive reserve. Association with severity of impairment in Alzheimer's disease. Br. J. Psychiatry 169, 86-92 (1996).
41. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 45, 1707-1712 (1995).
42. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 54, 2072-2077 (2000).
43. Schmand B, Smit JH, Geerlings MI, Lindeboom J. The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis. Psychol. Med. 27, 1337-1344 (2000).
44. Paykel ES, Brayne C, Huppert FA et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch. Gen. Psychiatry 51, 325-332 (1994).
45. Panza F, Capurso C, D'Introno A et al. Mediterranean diet, mild cognitive impairment, and Alzheimer's disease. Exp. Gerontol. 42, 6-7 (2007).
46. Solfrizzi V, Colacicco AM, D'Introno A et al. Dietary polyunsaturated fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging. Exp. Gerontol. 41, 619-627 (2006).
47. Solfrizzi V, Colacicco AM, D'Introno A et al. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol. Aging 27, 1694-1704 (2006).
48. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T et al. ω 3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study: a randomized double-blind trial. Arch. Neurol. 63, 1402-1408 (2006). • In this randomized, double-blind trial, following treatment the authors found that supplementation did not delay the rate of cognitive decline, but in the group of 32 patients with the most mild Alzheimer's disease (AD; Mini-Mental State Examination [MMSE] >27, Clinical Dementia Rating Score: 0.5-1), ω-3 polyunsaturated fatty acid supplementation slowed the decline in MMSE scores.
49. Greenwood CE, Winocur G. Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake. Behav. Neurosci. 110, 451-459 (1996).
50. Winocur G, Greenwood CE. The effects of high fat diets and environmental influences on cognitive performance in rats. Behav. Brain Res. 101, 153-161 (1999).
51. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann. Neurol. 42, 776-782 (1997).
52. Panza F, Solfrizzi V, Colacicco AM et al. Mediterranean diet and cognitive decline. Public Health Nutr. 7, 959-963 (2004).
53. Perrig WJ, Perrig P, Stehelin B. The relation between antioxidants and memory performance in the old and very old. J. Am. Geriatr. Soc. 45, 718-724 (1997).
54. Perkins AJ, Hendrie HC, Callahan CM et al. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 150, 37-44 (1999).
55. Paleologos M, Cumming RG, Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am. J. Epidemiol. 148, 45-50 (1998).
56. Riggs KM, Spiro A III, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine in cognitive performance in the Normative Aging Study. Am. J. Clin. Nutr. 63, 306-314 (1996).
57. Tucker DM, Penland JG, Sandstead HH, Milne DB, Heck DG, Klevay LM. Nutrition status and brain function in aging. Am. J. Clin. Nutr. 52, 93-102 (1990).
58. La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ. Nutritional status and cognitive functioning in a normally aging sample: a 6-year reassessment. Am. J. Clin. Nutr. 65, 20-29 (1997).
59. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report a pilot study. J. Am. Geriatr. Soc. 40, 168-172 (1992).
60. Joseph JA, Shukitt-Hale B, Denisova NA et al. Reversals of age-related declines in neuronal signal-transduction, cognitive and motor behavioral deficits with blueberry, spinach or strawberry, dietary supplementation. J. Neurosci. 19, 8114-8121 (1999).
61. Morris MS. Homocysteine and Alzheimer's disease. Lancet Neurol. 2 425-428 (2003).
62. Panza F, Solfrizzi V, D'Introno A, Capurso S, Capurso A. The role of micronutrients in cognitive decline and dementia. In: Diet and Cognitive Decline. Panza F, Solfrizzi V, Capurso A (Eds). Nova Science Publishers, Inc., NY, USA 35-58 (2004).
63. Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483 (2002).
64. Quadri P, Fragiacomo C, Pezzati R et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 80, 114-122 (2004).
65. Kruman II, Kumaravel TS, Lohani A et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22, 1752-1762 (2002).
66. Pradignac A, Schlienger JL, Velten M, Mejean L. Relationships between macronutrient intake, handicaps, and cognitive impairments in free living elderly people. Aging Clin. Exp. Res. 7, 67-74 (1995).
67. Del Parigi A, Panza F, Capurso C, Solfrizzi V. Nutritional factors, cognitive decline, and dementia. Brain Res. Bull. 69, 1-19 (2006).
68. Dye L, Lluch A, Blundell JE. Macronutrients and mental performance. Nutrition 16, 1021-1034 (2000).
69. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173, 149-152 (1971).
70. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178, 414-416 (1972).
71. Teff KL, Young SN, Blundell JE. The effect of protein or carbohydrate breakfasts on subsequent plasma amino acid levels, satiety and nutrient selection in normal males. Pharmacol. Biochem. Behav. 34, 829-837 (1989).
72. Ashley DV, Liardon R, Leathwood PD. Breakfast meal composition influences plasmatryptophan to large neutral amino acid ratios of healthy lean young men. J. Neural. Transm. 63, 271-283 (1985)
73. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol. Med. 20, 785-791 (1990).
74. Kaye WH, Gwirtsman HE, Brewerton TD, George DT, Wurtman RJ. Bingeing behavior and plasma amino acids: a possible involvement of brain serotonin in bulimia nervosa. Psychiatry Res. 23, 31-43 (1988).
75. Ortega RM, Requejo AM, Andres P et al. Dietary intake and cognitive function in a group of elderly people. Am. J. Clin. Nutr. 66, 803-809 (1997).
76. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83-133 (1999).
77. Jarvis MJ. Does caffeine enhance absolute levels of cognitive performance? Psychopharmacology 110, 45-52 (1993).
78. Herbert LE, Scherr PA, Beckett LA et al. Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons. Am. J. Epidemiol. 137, 881-891 (1993).
79. Launer LJ, Feskens EJ, Kalmijn S, Kromhout D. Smoking, drinking, and thinking. The Zutphen Elderly Study. Am. J. Epidemiol. 143, 219-227 (1996).
80. Dufouil C, Ducimetiere P, Alperovitch A. Sex differences in the association between alcohol consumption and cognitive performance. EVA Study Group. Epidemiology of Vascular Aging. Am. J. Epidemiol. 146, 405-412 (1997).
81. Edelstein SL, Kritz-Silverstein D, Barrett-Connor E. Prospective association of smoking and alcohol use with cognitive function in an elderly cohort. J. Womens Health. 7, 1271-1281 (1998).
82. Leibovici D, Ritchie K, Ledesert B, Touchon J. The effects of wine and tobacco consumption on cognitive performance in the elderly: a longitudinal study of relative risk. Int. J. Epidemiol. 28, 77-81 (1999).
83. Elias PK, Elias MF, D'Agostino RB, Silbershatz H, Wolf PA. Alcohol consumption and cognitive performance in the Framingham Heart Study. Am. J. Epidemiol. 150, 580-589 (1999).
84. Galanis DJ, Joseph C, Masaki KH, Petrovich H, Ross GW, White L. A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia aging study. Am. J. Public Health 90, 1254-1259 (2000).
85. Cervilla A, Prince M, Mann A. Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J. Neurol. Neurosurg. Psychiatry 68, 622-626 (2000).
86. Cervilla JA, Prince M, Joels S, Lovestone S, Mann A. Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br. J. Psychiatry 177, 66-71 (2000).
87. Kalmijn S, van Boxtel MPJ, Verschuren MVM, Jolles J, Launer LJ. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am. J. Epidemiol. 156, 936-944 (2002).
88. Leroi I, Sheppard JM, Lyketsos CG. Cognitive function after 11.5 years of alcohol use: relation to alcohol use. Am. J. Epidemiol. 156, 747-752 (2002).
89. Anttila T, Helkala EL, Viitanen M et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. Br. Med. J. 329(7465), 539 (2004). • This was the first paper in which alcohol consumption in middle age showed a U-shaped relationship with risk of mild cognitive impairment (MCI) in old age. Only carriers of the APOE ε4 allele had an increased risk of dementia with increasing alcohol consumption
90. Espeland MA, Gu L, Masaki KH et al. Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. Am. J. Epidemiol. 161, 228-238 (2005).
91. Solfrizzi V, D'Introno A, Colacicco AM et al. for the Italian Longitudinal Study on Aging Working Group. Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology 68, 1790-1799 (2007).
92. Fillmore MT, Carscadden JL, Vogel-Sprott M. Alcohol, cognitive impairment and expectancies. J. Stud. Alcohol 59, 174-179 (1998).
93. Millar K, Hammersley RH, Finnigan F. Reduction of alcohol-induced performance impairment by prior ingestion of food. Br. J. Psychol. 83(Pt 2), 261-278 (1992).
94. Lloyd HM, Rogers PJ. Mood and cognitive performance improved by a small amount of alcohol given with a lunchtime meal. Behav. Pharmacol. 8, 188-195 (1997).
95. Finnigan F, Hammersley R, Millar K. Effects of meal composition on blood alcohol level, psychomotor performance and subjective state after ingestion of alcohol. Appetite 31, 361-375 (1998).
96. Solfrizzi V, Colacicco AM, D'Introno A et al. Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia. J. Alzheimers Dis. 10, 303-330 (2006).
97. Solfrizzi V, D'Introno A, Colacicco AM et al. Lifestyle-related factors, alcohol consumption, and mild cognitive impairment. J. Am. Geriatr. Soc. 55, 1679-1681 (2007).
98. Panza F, Capurso C, Solfrizzi V. Cardiovascular factors and cognitive impairment: a role for unsaturated fatty acids and mediterranean diet? Am. J. Cardiol. 98, 1120-1121 (2006).
99. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347, 1141-1145 (1996).
100. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53, 1937-1942 (1999).
101. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 28, 316-321 (1997).
102. Hofman A, Ott A, Breteler MM et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349, 151-154 (1997).
103. Mungas D, Cooper JK, Weiler PG, Gietzen D, Franzi C, Bernick C. Dietary preference for sweet foods in patients with dementia. J. Am. Geriatr. Soc. 38, 999-1007 (1990).
104. Wurtman RJ. Effects of their nutrient precursors on the synthesis and release of serotonin, the catecholamines, and acetylcholine: implications for behavioral disorders. Clin. Neuropharmacol. 11(Suppl. 1), S187 (1988).
105. Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J. Neural Transm. 105, 415-422 (1998).
106. Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J. Neural Transm. 109, 341-360 (2002).
107. Munch G, Schinzel R, Loske C et al. Alzheimer's disease - synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J. Neural Transm. 105, 439-461 (1998).
108. Otsuka M, Yamaguchi K, Ueki A. Similarities and differences between Alzheimer's disease and vascular dementia from the viewpoint of nutrition. Ann. NY Acad. Sci. 977, 155-161 (2002).
109. Ross GW, Petrovitch H, White LR et al. Characterization of risk factors for vascular dementia. The Honolulu-Asia Aging Study. Neurology 53, 337-343 (1999).
110. Huijbregts PP, Feskens EJ, Rasanen L et al. Dietary intake in five ageing cohorts of men in Finland, Italy, and the Netherlands. Eur. J. Clin. Nutr. 49, 852-860 (1995).
111. Huijbregts PP, Feskens EJ, Rasanen L et al. Dietary patterns and cognitive function in elderly men in Finland, Italy, and the Netherlands. Eur. J. Clin. Nutr. 52, 826-831 (1998).
112. Gonzalez-Gross M, Marcos A, Pietrzik K. Nutrition and cognitive impairment in the elderly. Br. J. Nutr. 86, 313-321 (1997).
113. Fekkes D, van der Cammen TJ, van Loon CP et al. Abnormal amino acid metabolism in patients with early stage Alzheimer dementia. J. Neural. Transm. 105, 287-294 (1998).
114. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178, 414-416 (1972).
115. Riedel WJ, Jorissen BL. Nutrients, age and cognitive function. Curr. Opin. Clin. Nutr. Metab. Care 1, 579-585 (1998).
116. Rogers RD, Everitt BJ, Baldacchino A et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophandepleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20, 322-339 (1999).
117. Hendrie HC, Osuntokun BO, Hall KS et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am. J. Psychiatry 152, 1485-1492 (1995).
118. White L, Petrovitch H, Ross GW et al. Prevalence of dementia in older Japanese-American men in Hawaii. JAMA 276, 955-960 (1996).
119. Grant WB. Dietary links to Alzheimer's disease. Alz. Dis. Rev. 2, 42-55 (1997).
120. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann. Neurol. 42, 776-782 (1997).
121. Morris MC, Evans DA, Bienias JL et al. Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 60, 194-200 (2003).
122. Morris MC, Evans DA, Bienias JL et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 60, 940-946 (2003).
123. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. Br. Med. J. 325, 932-933 (2002).
124. Larrieu S, Letenneur L, Helmer C, Dartigues JF, Barberger-Gateau P. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J. Nutr. Health Aging 8, 150-154 (2004).
125. Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 59, 1258-1263 (2002).
126. Solfrizzi V, Panza F, Torres F et al. High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology 52, 1563-1569 (1999).
127. Solfrizzi V, D'Introno A, Colacicco AM et al. Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp. Gerontol. 40, 257-270 (2005).
128. Grant WB. Dietary links to Alzheimer's disease: 1999 Update. J. Alzheimer Dis. 1, 197-201 (1999).
129. Gibson RS. Content and bioavailability of trace elements in vegetarian diets. Am. J. Clin. Nutr. 59(5 Suppl.), S1223-S1232 (1994).
130. Gibson RS, Heath AL, Limbaga ML, Prosser N, Skeaff CM. Are changes in food consumption patterns associated with lower biochemical zinc status among women from Dunedin, New Zealand? Br. J. Nutr. 86, 71-80 (2001).
131. Lonnerdal B. Dietary factors influencing zinc absorption. J. Nutr. 130(5S Suppl.), S1378-S1383 (2000).
132. Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer's disease. Am. J. Med. 120, 388-397 (2007).
133. Korczyn AD, Vakhapova V. The prevention of the dementia epidemic. J. Neurol. Sci. 257, 2-4 (2007).
134. Korczyn AD. The complex nosological concept of vascular dementia. J. Neurol. Sci. 203-204, 3-6 (2002).
135. Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J. Neurol. Sci. 203-204, 7-10 (2002).
136. Kalaria RN. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc. Dis. Suppl. 2, 48-52 (2002).
137. DeKosky ST. Statin therapy in the treatment of Alzheimer disease: what is the rationale? Am. J. Med. 118(Suppl. 2A), 48-53 (2005).
138. Sparks DL, Sabbagh MN, Connor DJ et al. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch. Neurol. 62, 753-757 (2005).
139. Lim WS, Gammack JK, Van Niekerk J, Dangour AD. Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst. Rev. 25, CD005379 (2006).
140. Panza F, Capurso C, D'Introno A et al. Dietary polyunsaturated fatty acid supplementation, pre-dementia syndromes, and Alzheimer's disease. J. Am. Geriatr. Soc. 55, 469-470 (2007).
141. Kotani S, Sakaguchi E, Warashina S et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci. Res. 56, 159-164 (2006).
142. Mielke R, Moller HJ, Erkinjuntti T, Rosenkranz B, Rother M, Kittner B. Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of Phase I and Phase II clinical trials. Alzheimer Dis. Assoc. Disord. 12(Suppl. 2), S29-S35 (1998).
143. de Mendonca A, Sebastiao AM, Ribeiro JA. Adenosine: does it have a neuroprotective role after all? Brain. Res. Rev. 33, 258-274 (2000).
144. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83-133 (1999).
145. Maia L, de Mendonca A. Does caffeine intake protect from Alzheimer's disease? Eur. J. Neurol. 9, 377-382 (2002).
146. Ross GW, Abbott RD, Petrovitch H et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283, 2674-2679 (2000).
147. Orgogozo JM, Dartigues JF, Lafont S et al. Wine consumption and the elderly: a prospective community study in the Bordeaux area. Rev. Neur. 153, 185-192 (1997).
148. Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J. Nutr. 128, 1003-1007 (1998).
149. Ruitenberg A, van Swieten JC, Witteman JC et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 359, 281-286 (2002).
150. Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT Jr, Mittleman MA, Siscovick DS. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 289, 1405-1413 (2003).
151. Truelsen T, Thudium D, Grønbæk M. Amount and type of alcohol and risk of dementia: the Copenhagen city heart study. Neurology 59, 1313-1319 (2002).
152. Dufouil C, Tzourio C, Brayne C, Berr C, Amouyel P, Alperovitch A. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology 11, 280-284 (2000).
153. Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R. Alcohol intake and risk of dementia. J. Am. Geriatr. Soc. 52, 540-546 (2004).
154. Lindsay J, Laurin D, Verreault R et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am. J. Epidemiol. 156, 445-453 (2002).
155. Huang W, Qiu C, Winblad B, Fratiglioni L. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J. Clin. Epidemiol. 55, 959-964 (2002).
156. Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1, 507-537 (2000).
157. Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline. J. Neural Transm. 110, 95-110 (2003).
158. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann. Neurol. 59, 912-921 (2006). • The study by Scarmeas and colleagues provides another reminder that the preservation of certain dietary and lifestyle traditions may have important health consequences, and that the advantages of the Mediterranean diet are transferable to other populations, but unfortunately one of the hallmarks of this dietary pattern (median daily intake of monounsaturated fatty acids to saturated fatty acids ratio) may be not fulfilled in this study population.
159. Solfrizzi V, Capurso C, Panza F. Adherence to a Mediterranean dietary pattern and risk for Alzheimer's disease. Ann. Neurol. 60, 620 (2006).
160. Trichopoulou A, Kouris-Blazos A, Wahlqvist ML et al. Diet and overall survival in elderly people, Br. Med. J. 311, 1457-1460 (1995).
161. Hu FB, Bronner L, Willett WC et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287, 1815-1821 (2002).
162. Solfrizzi V, Capurso C, D'Introno A, Colacicco AM, Capurso A, Panza F. Whole-diet approach and risk of chronic disease: limits and advantages. J. Am. Geriatr. Soc. 54, 1800-1802 (2006).
163. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 348, 2599-2608 (2003).
164. Small GW, Silverman DH, Siddarth P et al. Effects of a 14-day healthy longevity lifestyle program on cognition and brain function, Am. J. Geriatr. Psychiatry 14, 538-545 (2006). • Demonstrates that in just 14 days, simple lifestyle changes can not only help overall health, but also improve memory and brain function. The next step is to assess the individual effects of each lifestyle strategy, which may help us develop an optimal combination.
165. Panza F, Capurso C, D'Introno A et al. Possible role of unsaturated fatty acids in a 14-day healthy longevity lifestyle program. Am. J. Geriatr. Psychiatry 15, 266 (2007).
166. Rejeski WJ, Fielding RA, Blair SN et al. The lifestyle interventions and independence for elders (LIFE) pilot study: design and methods. Contemp. Clin. Trials 26, 141-154 (2005).
167. LIFE Study Investigators, Pahor M, Blair SN, Espeland M et al. Effects of a physical activity interventions on measures of physical performance: results of the Lifestyle Interventions For independence in Elders Pilot (LIFE-P) study. J. Gerontol. A Biol. Sci. Med. Sci. 61, 1157-1165 (2006).
168. Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch. Intern. Med. 161, 1703-1708 (2001).
169. Barnes DE, Yaffe K, Satariano WA, Tager IB. A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J. Am. Geriatr. Soc. 51, 459-465 (2003).
170. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol. 58, 498-504 (2001).
171. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H. Walking and dementia in physically capable elderly men. JAMA 292, 1447-1453 (2004).
172. Larson EB, Wang L, Bowen JD et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 144, 73-81 (2006).
173. Dustman RE, Ruhling RO, Russell EM et al. Aerobic exercise training and improved neuropsychological function of older individuals. Neurobiol. Aging 5, 35-42 (1984).
174. Kramer AF, Hahn S, Cohen NJ et al. Ageing, fitness and neurocognitive function. Nature 400, 418-419 (1999).
175. Rikli RE, Edwards DJ. Effects of a three-year exercise program on motor function and cognitive processing speed in older women. Res. Q Exerc. Sport 62, 61-67 (1991).
176. Hill RD, Storandt M, Malley M. The impact of long-term exercise training on psychological function in older adults. J. Gerontol. 48, 12-17 (1993).
177. Madden DJ, Blumenthal JA, Allen PA, Emery CF. Improving aerobic capacity in healthy older adults does not necessarily lead to improved cognitive performance. Psychol. Aging 4, 307-320 (1989).
178. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol. Sci. 14, 125-130 (2003).
179. West RL. An application of prefrontal cortex function theory to cognitive aging. Psychol. Bull. 120, 272-292 (1996).
180. Kramer AF, Humphrey DG, Larish JF, Logan GD, Strayer DL. Aging and inhibition: beyond a unitary view of inhibitory processing in attention. Psychol. Aging 9, 491-512 (1994).
181. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol. 58, 498-504 (2001).
182. Lindsay J, Laurin D, Verreault R et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol. 156, 445-453 (2002).
183. Podewills LJ, Guallar E, Kuller LH et al. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am. J. Epidemiol. 161, 639-651 (2005).
184. Verghese J, Lipton RB, Katz MJ et al. Leisure activities and the risk of dementia in the elderly. N. Engl. J. Med. 348, 2508-2516 (2003).
185. Abbott RD, White LR, Ross GW et al. Walking and dementia in physically capable elderly men. JAMA 292, 1447-1453 (2004).
186. Broe GA, Creasey H, Jorm AF et al. Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Aust. NZ J. Public Health 22, 621-623 (1998).
187. Wilson RJ, Bennett DA, Bienias JL et al. Cognitive activity and incident AD in a population-based sample of older persons. Neurology 59, 1910-1914 (2002).
188. Fabrigoule C, Letenneur L, Dartigues JF et al. Social and leisure activities and risk of dementia: a prospective longitudinal study. J. Am. Geriatr. Soc. 43, 485-490 (1995).
189. Wang HX, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen Project. Am. J. Epidemiol. 155, 1081-1087 (2002).
190. Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G. Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J. Am. Geriatr. Soc. 51, 410-414 (2003).
191. Rovio S, Kareholt I, Helkala EL et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 4, 705-711 (2005). • This paper suggested that leisure-time physical activity at midlife (on average 21 years before the diagnosis of dementia) is related to a decreased risk of dementia and AD, suggesting that the time of measurement of possible leisure-time physical activity may be important.
192. Friedland RP, Fritsch T, Smyth KA et al. Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc. Natl Acad. Sci. USA 98, 3440-3445 (2001).
193. Verghese J, LeValley A, Derby C et al. Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology 66, 821-827 (2006). • In this paper, cognitive leisure activities appeared to be protective against incident amnestic MCI, suggesting possible different mechanisms of protection for cognitive- and physical-related leisure activities in predementia syndromes.
194. Wilson RS, Mendes De Leon CF, Barnes LL et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 287, 742-748 (2002).
195. Noah A, Truswell AS. There are many Mediterranean diets. Asia Pac. J. Clin. Nutr. 10(1), 2-9 (2001).
196. Gascon-Bayarri J, Rene R, Del Barrio JL et al. Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study. Neuroepidemiology 28, 224-234 (2007).
197. Letenneur L, Dequae L, Jacqmin H et al. [Prevalence of dementia in Gironde (France)] Rev. Epidemiol. Sante Publique 41, 139-145 (1993).
198. The Italian Longitudinal Study on Aging Working Group. Prevalence of chronic diseases in older Italians: comparing selfreported and clinical diagnoses. Int. J. Epidemiol. 26, 995-1002 (1997).
199. Argyriadou S, Melissopoulou H, Krania E, Karagiannidou A, Vlachonicolis I, Lionis C. Dementia and depression: two frequent disorders of the aged in primary health care in Greece. Fam. Pract. 18, 87-91 (2001).
200. Keskinoglu P, Giray H, Picakciefe M, Bilgic N, Ucku R. The prevalence and risk factors of dementia in the elderly population in a low socio-economic region of Izmir, Turkey. Arch. Gerontol. Geriatr. 43, 93-100 (2006).
201. Briante R, Febbraio F, Nucci R. Antioxidant properties of low molecular weight phenols present in the Mediterranean diet. J. Agric. Food Chem. 51, 6975-6981 (2003).
202. Joseph JA, Shukitt-Hale B, Denisova NA et al. Reversals of age-related declines in neuronal signal transduction, cognitive and motor behavioral deficits with blueberry, spinach or strawberry dietary supplementation. J. Neurosci. 19, 8114-8121 (1999).
203. Deschamps V, Barberger-Gateau P, Peuchant E, Orgogozo JM. Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress. Neuroepidemiology 20, 7-15 (2001).
204. Jones CB, Arai T, Rapoport SI. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. Neurochem. Res. 22, 663-670 (1997).
205. Favrelere S, Stadelmann-Ingrand S, Huguet F et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol. Aging 21, 653-660 (2000).
206. Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 8, 163-174 (2004).
207. Bourre JM, Dumont OL, Clement ME, Durand GA. Endogenous synthesis cannot compensate for absence of dietary oleic acid in rats. J. Nutr. 127, 488-493 (1997).
208. Williams P, Forsyth JS, DiMondugno MK, Varma S, Colvin M. Effects of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 352, 688-691 (1998).
209. Delion S, Chalon S, Hearault J, Guilloteau D, Besnard J-C, Durand G. Chronic dietary-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J. Nutr. 124, 2466-2476 (1994).
210. Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid [DHA]. Pharmacol. Res. 40, 211-225 (1999).
211. Keli SO, Feskens EJ, Kromhout D. Fish consumption and risk of stroke. The Zutphen Study. Stroke 25, 328-332 (1994).
212. Marchiali R, Barzi F, Bomba E et al. GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico [GISSI]-Prevenzione. Circulation 105, 1897-1903 (2002).
213. Panza F, D'Introno A, Colacicco AM et al. Vascular risk and genetics of sporadic lateonset Alzheimer's disease. J. Neural. Transm. 111, 69-89 (2004).
214. Crawford MA, Bloom M, Broadhurst CL et al. Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain. Lipids 34(Suppl.), S39-S47 (1999).
215. Alsted AL, Hoy CE. Fatty acid profiles of brain phospholipid subclasses of rats fed n-3 polyunsaturated fatty acids of marine or vegetable origin. A two generation study. Biochim. Biophys. Acta 1125, 237-244 (1992).
216. Reaven PD, Grasse BJ, Tribble DL. Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler. Thromb. 14, 557-566 (1994).
217. Blankenhorn DH, Johnson RL, Mack WJ, el Zein HA, Vailas LI. The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 263, 1646-1652 (1990).
218. de Lorgeril M, Salen P, Martin JL, Monjaud I, Boucher P, Mamelle N. Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Arch. Intern. Med. 158, 1181-1187 (1998).
219. McGeer PL, McGeer EG. The inflammatory response system of brain: Implications for therapy of Alzheimer and neurodegenerative diseases. Brain Res. Rev. 21, 195-218 (1995).
220. Ambring A, Friberg P, Axelsen M et al. Effects of a Mediterranean-inspired diet on blood lipids, vascular function and oxidative stress in healthy subjects. Clin. Sci. 106, 519-525 (2004).
221. Notkola IL, Sulkava R, Pekkanen J et al. Serum total cholesterol, apolipoprotein E e4 allele, and Alzheimer's disease. Neuroepidemiology 17, 14-20 (1998).
222. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 45, 1092-1096 (1995).
223. Kuusisto J, Koivisto K, Mykkanen L et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. Br. Med. J. 315, 1045-1049 (1997).
224. Solfrizzi V, Panza F, D'Introno A et al. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 72, 732-736 (2002).
225. Urakami K, Wada-Isoe K, Wakutani Y et al. Lipoprotein[a] phenotypes in patients with vascular dementia. Dement. Geriatr. Cogn. Disord. 11, 135-138 (2000).
226. Kuo YM, Emmerling MR, Bisgaier CL et al. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain Ab 1-42 levels. Biochem. Biophys. Res. Comm. 252, 711-715 (1998).
227. Palomaki H, Kaste M. Regular light-tomoderate intake of alcohol and the risk of ischemic stroke: is there a beneficial effect? Stroke 24, 1828-1832 (1993).
228. den Heijer T, Vermeer SE, van Dijk EJ et al. Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia. Am. J. Clin. Nutr. 80, 992-997 (2004).
229. Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog. Neurobiol. 56, 385-431 (1998).
230. Ladolfi R, Steiner M. Ethanol raises prostacyclin level in vivo and in vitro. Blood 64, 679-682 (1984).
231. Rubin R, Rand ML. Alcohol and platelet function. Alcohol Clin. Exp. Res. 18, 105-110 (1994).
232. Ridker PM, Vaughan DE, Stampfer MJ et al. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 272, 929-933 (1994).
233. Meade TW, Chakrabarti R, Haines AP et al. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br. Med. J. 1, 153-156 (1979).
234. Gaziano JM, Buring JE, Breslow JL et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N. Engl. J. Med. 329, 1829-1834 (1993).
235. Camargo CA Jr, Williams PT, Vranizan KM et al. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. A controlled study. JAMA 253. 2854-2857 (1985).
236. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biologic pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 85, 910-915 (1992).
237. Howard A, Chopra M, Thurnman D et al. Red wine consumption an inhibition of LDL oxidation: What are the important components? Med. Hypotheses 59, 101 (2002).
238. Bertelli AA, Migliori M, Panichi V et al. Oxidative stress and inflammatory reaction modulation by white wine. Ann. NY Acad. Sci. 957, 295-301 (2002).
239. Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J. Nutr. 128, 1003-1007 (1998).
240. Heinonen IM, Lehtonen PJ, Hopia AI. Antioxidant activity of berry and fruit wines and liquors. J. Agric. Food Chem. 46, 25-31 (1998).
241. Anstey K, Christensen H. Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: a review. Gerontology 46, 163-177 (2000).
242. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354, 919-920 (1999).
243. Colsher PL, Wallace RB. Epidemiologic considerations in studies of cognitive function in the elderly: methodology and nondementing acquired dysfunction. Epidemiol. Rev. 13, 1-27 (1991).
244. Long DM. Aging in the nervous system. Neurosurgery 17, 348-354 (1985).
245. Rogers RL, Meyer JS, Mortel KF. After reaching retirement age physical activity sustains cerebral perfusion and cognition. J. Am. Geriatr. Soc. 38, 123-128 (1990).
246. Churchill JD, Galvez R, Colcombe S, Swain RA, Kramer AF, Greenough WT. Exercise, experience and the aging brain. Neurobiol. Aging 23, 941-955 (2002).
247. Black JE, Isaacs KR, Anderson BJ, Alcantara AA, Greenough WT. Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats. Proc. Natl Acad. Sci. USA 87, 5568-5572 (1990).
248. van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl Acad. Sci. USA 96, 13427-13431 (1999).
249. van Praag H, Shubert T, Zhao C, Gage FH. Exercise enhances learning and hippocampal neurogenesis in aged mice. J. Neurosci. 25, 8680-8685 (2005).
250. Vaynman SS, Ying Z, Yin D, Gomez-Pinilla F. Exercise differentially regulates synaptic proteins associated to the function of BDNF. Brain Res. 1070, 124-130 (2006).
251. Berchtold NC, Kesslak JP, Pike CJ, Adlard PA, Cotman CW. Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur. J. Neurosci. 14, 1992-2002 (2001).
252. Carro E, Trejo JL, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J. Neurosci. 21, 5678-5684 (2001).
253. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 25, 295-301 (2002).
254. Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J. Neurosci. 25, 4217-4221 (2005).
255. Radak Z, Kaneko T, Tahara S et al. Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem. Int. 38, 17-23 (2001).
256. Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler. Thromb. Vasc. Biol. 22, 1869-1876 (2002).
257. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am. J. Cardiol. 84, 1018-1022 (1999).
258. Das UN. Anti-inflammatory nature of exercise. Nutrition 20, 323-326 (2004).
259. Grammas P, Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol. Aging 22, 837-842 (2001).
260. Yaffe K, Lindquist K, Penninx BW et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61, 76-80 (2003).
261. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7, 284-301 (1986).
262. Belanoff JK, Gross K, Yager A, Schatzberg AF. Corticosteroids and cognition. J. Psychiatr. Res. 35, 127-145 (2001).
263. Del Ser T, Hachinski V, Merskey H, Munoz DG. An autopsy-verified study of the effect of education on degenerative dementia. Brain 122(Pt 12), 2309-2319 (1999).
264. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology 43, 13-20 (1993).
265. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc. 8, 448-460 (2002).
266. Lands WEM, Pawlosky RJ, Salem N Jr. Alcoholism, antioxidant status, and essential fatty acids. In: Antioxidant Status, Diet, Nutrition, and Health. Papas AM (Ed). CRC Press, FL, USA 299-344 (1999).
267. Harris RA, Baxter DM, Mitchell MA, Hitzemann RJ. Physical properties and lipid composition of brain membranes from ethanol tolerant dependent mice. Mol. Pharmacol. 25, 401-409 (1984).
268. Pawlosky RJ, Salem N Jr. Ethanol exposure causes a decrease in docosahexaenoic acid and an increase in docosapentaenoic acid in feline brains and retinas. Am. J. Clin. Nutr. 61, 1284-1289 (1995).
269. Salem N Jr, Reyzer M, Karanian J. Losses of arachidonic acid in rat liver after alcohol inhalation. Lipids 31(Suppl.), S153-S156 (1996).
270. Debski B, Bertrandt J, Klos A, Gralak M. The influence of folic acid, vitamins B2 and B6 supplementation on feed intake, body and organs weight, and liver fatty acids composition of rats subjected to 3 months moderate protein deprivation. J. Vet. Med. A Physiol. Pathol. Clin. Med. 54, 57-61 (2007).
271. Eritsland J. Safety considerations of polyunsaturated fatty acids. Am. J. Clin. Nutr. 71(1 Suppl.), S197-S201 (2000).
272. Conquer JA, Roelfsema H, Zecevic J, Graham TE, Holub BJ. Effect of exercise on FA profiles in n-3 FA-supplemented and -nonsupplemented premenopausal women. Lipids 37, 947-951 (2002).
273. Bopp M, Lovelady C, Hunter C, Kinsella T. Maternal diet and exercise: effects on long-chain polyunsaturated fatty acid concentrations in breast milk. J. Am. Diet. Assoc. 105, 1098-1103 (2005).
274. Ball K, Berch DB, Helmers KF et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA 288, 2271-2281 (2002).
275. Spector A, Thorgrimsen L, Woods B et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br. J. Psychiatry 183, 248-254 (2003).